Cystic fibrosis modifier genes related to Pseudomonas aeruginosa infection

Genes and Immunity

Volumn 12, Issue 5, 2011, Pages 370-377

  Park, J E ^a   Yung, R ^a   Stefanowicz, D ^a   Shumansky, K ^a   Akhabir, L ^a   Durie, P R ^b   Corey, M ^b   Zielenski, J ^b   Dorfman, R ^b   Daley, D ^a   Sandford, A J ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

Cystic fibrosis; lung function; modifier genes; Pseudomonas

Indexed keywords

ALTERNATIVE COMPLEMENT PATHWAY C3 C5 CONVERTASE; COMPLEMENT COMPONENT C3; HEME OXYGENASE 1; TOLL LIKE RECEPTOR 4; TRANSMEMBRANE CONDUCTANCE REGULATOR;

ADULT; ARTICLE; CHILD; COHORT ANALYSIS; CYSTIC FIBROSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; DNA POLYMORPHISM; FEMALE; GENETIC ASSOCIATION; HUMAN; LUNG FUNCTION; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; PSEUDOMONAS INFECTION; SCHOOL CHILD;

ADOLESCENT; ADULT; AGE FACTORS; ALLELES; CHILD; CHILD, PRESCHOOL; CYSTIC FIBROSIS; FEMALE; GENES, MODIFIER; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INFANT; INFANT, NEWBORN; MALE; META-ANALYSIS AS TOPIC; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; YOUNG ADULT;

PSEUDOMONAS; PSEUDOMONAS AERUGINOSA;

EID: 79960648956     PISSN: 14664879     EISSN: 14765470     Source Type: Journal    
DOI: 10.1038/gene.2011.5     Document Type: Article

References (22)

1. Bobadilla JL, Macek Jr M, Fine JP, Farrell PM. Cystic fibrosis: a worldwide analysis of CFTR mutations-correlation with incidence data and application to screening. Hum Mutat 2002; 19: 575-606. (Pubitemid 34556480)
2. Kerem E, Corey M, Kerem BS, Rommens J, Markiewicz D, Levison H et al. The relation between genotype and phenotype in cystic fibrosis-analysis of the most common mutation (DF508). N Engl J Med 1990; 323: 1517-1522.
3. Johansen HK, Nir M, Hoiby N, Koch C, Schwartz M. Severity of cystic fibrosis in patients homozygous and heterozygous for DF508 mutation. Lancet 1991; 337: 631-634.
4. Burke W, Aitken ML, Chen SH, Scott CR. Variable severity of pulmonary disease in adults with identical cystic fibrosis mutations. Chest 1992; 102: 506-509.
5. Santis G, Osborne L, Knight RA, Hodson ME. Independent genetic determinants of pancreatic and pulmonary status in cystic fibrosis. Lancet 1990; 336: 1081-1084. (Pubitemid 20368740)
6. Mekus F, Ballmann M, Bronsveld I, Bijman J, Veeze H, Tummler B. Categories of DF508 homozygous cystic fibrosis twin and sibling pairs with distinct phenotypic characteristics. Twin Res 2000; 3: 277-293. (Pubitemid 32126931)
7. Vanscoy LL, Blackman SM, Collaco JM, Bowers A, Lai T, Naughton K et al. Heritability of lung disease severity in cystic fibrosis. Am J Respir Crit Care Med 2007; 175: 1036-1043. (Pubitemid 46741755)
8. Drumm ML, KonstanMW, Schluchter MD, Handler A, Pace R, Zou F et al. Genetic modifiers of lung disease in cystic fibrosis. N Engl J Med 2005; 353: 1443-1453. (Pubitemid 41400918)
9. Dorfman R, Sandford A, Taylor C, Huang B, Frangolias D, Wang Y et al. Complex two-gene modulation of lung disease severity in children with cystic fibrosis. J Clin Invest 2008; 118: 1040-1049. (Pubitemid 351364611)
10. Hillian AD, Londono D, Dunn JM, Goddard KA, Pace RG, Knowles MR et al. Modulation of cystic fibrosis lung disease by variants in interleukin-8. Genes Immun 2008; 9: 501-508.
11. Taylor-Cousar JL, Zariwala MA, Burch LH, Pace RG, Drumm ML, Calloway H et al. Histo-blood group gene polymorphisms as potential genetic modifiers of infection and cystic fibrosis lung disease severity. PLoS One 2009; 4: e4270.
12. Gu Y, Harley IT, Henderson LB, Aronow BJ, Vietor I, Huber LA et al. Identification of IFRD1 as a modifier gene for cystic fibrosis lung disease. Nature 2009; 458: 1039-1042.
13. Hoiby N, Flensborg EW, Beck B, Friis B, Jacobsen SV, Jacobsen L. Pseudomonas aeruginosa infection in cystic fibrosis. Diagnostic and prognostic significance of Pseudomonas aeruginosa precipitins determined by means of crossed immunoelectrophoresis. Scand J Respir Dis 1977; 58: 65-79.
14. Wilmott RW, Tyson SL, Matthew DJ. Cystic fibrosis survival rates. The influences of allergy and Pseudomonas aeruginosa. Am J Dis Child 1985; 139: 669-671. (Pubitemid 15006401)
15. Currie AJ, Speert DP, Davidson DJ. Pseudomonas aeruginosa: role in the pathogenesis of the CF lung lesion. Semin Respir Crit Care Med 2003; 24: 671-680. (Pubitemid 38036762)
16. Mueller-Ortiz SL, Drouin SM, Wetsel RA. The alternative activation pathway and complement component C3 are critical for a protective immune response against Pseudomonas aeruginosa in a murine model of pneumonia. Infect Immun 2004; 72: 2899-2906. (Pubitemid 38542420)
17. Zhou H, Lu F, Latham C, Zander DS, Visner GA. Heme oxygenase-1 expression in human lungs with cystic fibrosis and cytoprotective effects against Pseudomonas aeruginosa in vitro. Am J Respir Crit Care Med 2004; 170: 633-640. (Pubitemid 39202205)
18. Nyholt DR. A simple correction for multiple testing for singlenucleotide polymorphisms in linkage disequilibrium with each other. Am J Hum Genet 2004; 74: 765-769. (Pubitemid 38420107)
19. Carlson CS, Eberle MA, Rieder MJ, Yi Q, Kruglyak L, Nickerson DA. Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium. Am J Hum Genet 2004; 74: 106-120. (Pubitemid 38085242)
20. Horvath S, Xu X, Laird NM. The family based association test method: strategies for studying general genotype-phenotype associations. Eur J Hum Genet 2001; 9: 301-306. (Pubitemid 32366699)
21. Wang X, Dockery DW, Wypij D, Fay ME, Ferris Jr BG. Pulmonary function between 6 and 18 years of age. Pediatr Pulmonol 1993; 15: 75-88.
22. Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med 1999; 159: 179-187. (Pubitemid 29036522)